These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 702290)

  • 1. Disposition of norgestimate in the presence and absence of ethinyl estradiol after oral administration to humans.
    Weintraub HS; Abrams LS; Patrick JE; McGuire JL
    J Pharm Sci; 1978 Oct; 67(10):1406-8. PubMed ID: 702290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
    Zhu B; Nestorov I; Zhao G; Meka V; Leahy M; Kam J; Sheikh SI
    Clin Pharmacol Drug Dev; 2017 Nov; 6(6):604-613. PubMed ID: 28783872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.
    Trapnell CB; Connolly M; Pentikis H; Forbes WP; Bettenhausen DK
    Ann Pharmacother; 2007 Feb; 41(2):222-8. PubMed ID: 17284510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
    Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
    Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a clinically important pharmacokinetic interaction between sofosbuvir or ledipasvir and hormonal oral contraceptives norgestimate/ethinyl estradiol in HCV-uninfected female subjects.
    German P; Moorehead L; Pang P; Vimal M; Mathias A
    J Clin Pharmacol; 2014 Nov; 54(11):1290-8. PubMed ID: 24925712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.
    Anderson MS; Hanley WD; Moreau AR; Jin B; Bieberdorf FA; Kost JT; Wenning LA; Stone JA; Wagner JA; Iwamoto M
    Br J Clin Pharmacol; 2011 Apr; 71(4):616-20. PubMed ID: 21395656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women.
    Runnebaum B; Grunwald K; Rabe T
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1963-8. PubMed ID: 1605286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with a new norgestimate-containing oral contraceptive.
    Huber J
    Int J Fertil; 1992; 37 Suppl 1():47-53. PubMed ID: 1347520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
    Rubio-Lotvin B; Gonzales-Ansorena R
    Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
    Corson SL
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S; Kaye JA; Li L; Jick H
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
    Lawson JS; Yuliano SE; Pasquale SA; Osterman JJ
    Am J Obstet Gynecol; 1979 Jun; 134(3):315-20. PubMed ID: 377968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.
    Olson WH; Lippman JS; Robisch DM
    Int J Fertil Womens Med; 1998; 43(6):286-90. PubMed ID: 9920537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.